Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold - Concepedia

Concepedia

Publication | Open Access

Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold

DOI Full Paper Access

28

Citations

34

References

2014

Year

Paul Galatsis, Jaclyn L. Henderson, Bethany L. Kormos, Seungil Han, Ravi G. Kurumbail, Travis T. Wager, Patrick R. Verhoest, G. Stephen Noell, Yi Chen, Elie Needle,

Bioorganic & Medicinal Chemistry Letters

MedicineReceptor Tyrosine KinaseKinase Domain InhibitionMolecular BiologyPharmacologyPharmaceutical ChemistryDrug Discovery

References

	Year	Citations

Page 1

Page 1